null

PE Anti-Human CD37 Antibody [IPO-24] (AGEL2832)

SKU:
AGEL2832
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Applications:
FCM
Reactivity:
Human
Host Species:
Mouse
Isotype:
Mouse IgG2b, κ
Clone:
IPO-24
Conjugation:
PE
€189 - €629
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Human CD37 Antibody [IPO-24]

The CD37 Monoclonal Antibody (IPO-24) offered by AssayGenie is specifically designed for research involving the CD37 cell surface molecule. CD37 is known for its role in cell signaling and is a target for therapeutic antibodies in cancer treatments. This mouse monoclonal antibody, IPO-24, is highly specific for human CD37 and is validated for various applications, including flow cytometry and immunohistochemistry.CD37 is a crucial membrane protein involved in lymphocyte activation and proliferation, making it a key player in immune responses and cell cycle regulation. Research shows its potential as a therapeutic target in B-cell malignancies such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

The use of IPO-24 antibody enables the detection and analysis of CD37 expression in different cell types, providing valuable insights for immunology and oncology studies.By understanding the function and expression of CD37, researchers can further explore its role in disease pathology and develop targeted therapies that leverage its unique properties. The IPO-24 monoclonal antibody from AssayGenie offers researchers a reliable tool for investigating CD37 biology and its implications in cancer immunotherapy and other therapeutic approaches.